Computed Tomography (CT) in Head and Neck Patients

Lung Tumors Clinical Trial

Official title:
Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer

Status Terminated

Clinical Trial Summary

This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.

Clinical Trial Description

A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Lung Tumors

Clinical Trial Details

NCT number	NCT00188656
Study type	Interventional
Source	University Health Network, Toronto
Contact
Status	Terminated
Phase	Phase 1
Start date	August 2003
Completion date	September 2006

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01218529` - Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors	Phase 2
	Completed	`NCT02013297` - Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)	N/A